Quality is clearly deficient in many human embryos growing in vitro. Fewer than 20% implant after transfer to the uterus in the majority of patients, so two or more are replaced which results in high-order multiple pregnancies. Among many approaches to improving quality, co-culture with supporting cells has claimed to be successful (e.g. Bongso et al., 1994) , although it is now being replaced by the use of sequential culture media (Ménézo et al., 1998) . Zona drilling was also introduced to enhance implantation rates (Cohen et al., 1990) . In recent studies, co-cultures combined with assisted hatching failed to improve implantation rates above 23-26% per embryo, which were overall similar to controls (Hu et al., 1998) . Perhaps variations between clinics account for differences in the success of these approaches.
Growth and transfer of blastocysts, an approach widely used in domestic and laboratory animal species, is now being recommended by several authors, e.g. Bavister and Boatman (1997) , Gardner and Lane (1998) and Tsirigotis (1998) . Potentially, high implantation rates per embryo seem to be possible, allowing the transfer of only one or two embryos thereby avoiding multiple pregnancies. Blastocyst transfer is claimed to be more physiological than pronucleate and 2-cell transfers. This principle led to the first-ever clinical human pregnancy being established by blastocyst transfer (Steptoe and Edwards, 1978) . Blastocysts have been grown in vitro for many years, with rates approaching 50% of embryos cultured being achieved Ͼ10 years ago, although many failed to expand fully (Fishel and Edwards, 1983) . Expanded and hatching blastocysts were also cryopreserved, ready for a later transfer , Fehilly et al., 1985 .
In some clinics, modern media containing various additives such as hyaluronate and vitamins still yield low rates of development of cleaving human embryos to expanding or hatched blastocysts. One detailed study (Jones et al., 1998) utilized a cell-and serum-free system of sequential culture media, brief exposures of oocytes to spermatozoa, culture of 2-3 embryos in one microdrop from days 1-3, then transfer to another medium from days 3-5. Gardner's (1994) G1 and G2 media with added albumin were used in this study, in various protocols, and blastocysts required various intervals in culture, i.e. 5.5, 6.5 . and 7.5 days post-insemination. Overall © European Society of Human Reproduction and Embryology 1 20% of embryos developed into enlarging blastocysts. Desai et al. (1997) reported 45% of supernumary embryos reached blastocysts, with an inner cell mass in 82% of them. Another recent optimistic study on blastocyst culture in which heparinbinding epidermal growth factor (Hb-EGF) was added to embryos cultured from day 2-7 post-insemination, has also been reported (Martin et al., 1998) . Rates of blastocyst formation in high-grade cleaving embryos improved from 41 to 71% with 1 nM Hb-EGF and to 71% with 100 mM Hb-EGF. Hatching rates also improved from 46 to 71% and to 82%. The stimulatory effect of Hb-EGF was only apparent from the 8-cell stage. Results went in the opposite direction with low-grade cleaving embryos, with rates of blastulation and hatching declining from 36% in controls to 19% with 100 nM Hb-EGF. Blastocysts in the control and treated groups utilized similar amounts of glucose and pyruvate.
The proof of this pudding is in the proportion of blastocysts which implant after transfer. Implantation rates per blastocyst transferred in early studies did not exceed 30% Fehilly et al., 1985) , comparing favourably with the highest implantation rates with embryos grown in routine media and transferred on days 2-3, rarely exceeding 25% (e.g. Damario et al., 1997) . Early work with cryopreserved blastocysts reached implantation per blastocyst rates of 10% (Hartshorne et al., 1991) , although their morphological markers were unhelpful in predicting implantation. More recently, an overall pregnancy rate of 23% after the transfer of cryopreserved blastocysts could be divided into rates of 39% with early-blastulating embryos versus 6.2% with those blastulating on day 7 (Shoukir et al., 1998) . When this implantation rate is corrected for the number of embryos failing to reach blastocysts, i.e. 52.7%, the corrected implantation rate per fertilized egg is Ͻ20% in the optimal group. Very recently, in a study of fresh embryos, occasional morulae were added when insufficient blastocysts were available to enable transfer of 2-3 embryos. The overall rate of implantation was 22.6% per embryo (Jones et al., 1998) . This value is greatly reduced if calculated on the original number of fertilized embryos. Likewise, the transfer of four zona-free expanding and hatching-stage blastocysts in a single patient resulted in one singleton fetus (Fong et al., 1997) . In a study on culturing embryos for 5 days, then transferring blastocysts, implantation rates were 23% with the first treatment cycle, declining to 12% at cycle 4, although it seems that embryo numbers were made up with earlier-stage embryos if blastocysts were not available (Scholtes and Zeilmaker, 1998) . It is notable and cautionary that in this study 384 out of 929 (41%) patients did not achieve a single blastocyst in vitro, and this was suggested by the authors to be related to the ovarian function of the patient. Numbers of fertilized embryos established per patient were not quoted, but must have been fairly high since patients were stimulated with gonadotrophin-releasing hormone (GnRH) agonist/follicle stimulating hormone (FSH)/human chorionic gonadotrophin (HCG) protocols.
A comparative report from Gardner et al. (1998a) on transfers on day 3 or day 5 indicated implantation rates per embryo of 21% on day 3 (using mostly 7-8 cell embryos after assisted hatching) versus 46% on day 5 (using blastocysts). The blastocyst transfer group was composed of only eight patients, and only 38% of the original fertilized embryos reached blastocyst in one medium, while 66% reached blastocyst in another. A correction of 33% for those embryos failing to develop into blastocysts reduces the implantation rates in the two groups to 31 and 16% respectively in relation to the original number of fertilized embryos. This work was followed up by a prospective trial comparing day 3 and day 5 transfers in 47 and 45 patients respectively (Gardner et al., 1998b) . Although implantation rates per embryo increased from 30.1% in the day 3 group to 50.5% in the day 5 group (P Ͻ 0.01), the clinical pregnancy rates were similar at 66 and 71% respectively. Perhaps the improved implantation rates per embryo following culture to blastocyst can be explained purely in terms of selection of best embryos.
If achieved overall, implantation rates of~50% per blastocyst transferred (Gardner et al., 1998a,b) , even if many embryos die before day 5, would be a significant step forward, providing the means to reduce multiple birth rates, albeit perhaps in a selected patient group. It could also have scientific benefits in helping to clarify the processes of implantation. They have survived for 5 days in vitro which must be a token of quality. Why do 50% of them then fail to implant, when these are already the survivors from a much higher number of fertilized oocytes? Aneuploidy is a possible cause. Its frequency in human oocytes reportedly ranges from 25-50% of embryos (Boue et al., 1975; Plachot et al, 1988; Martini et al., 1997) . Losses in vivo and non-receptive endometrium could be other factors. It seems that similar failure rates occur in vivo. The human fecundability parameter measures events between sexual intercourse at the correct stage of the cycle and the occurrence of implantation. It varies between 0.15 and 0.35 in a normal population, and has a suggested mean value of 0.25; this means that 25% of couples should become pregnant within a month of trying (Basso et al., 1997; Spira, 1998) . In a recent study on the establishment of pregnancy in multiparous women after discontinuation of oral contraception, sperm quality and bleeding pattern and frequency were recorded in a population of 612 couples over six successive menstrual cycles. Pregnancy rates per cycle were consistently Ͻ20% in virtually all couples classified on various semen parameters. At the end of the trial, 256 pregnancies had been established after 1661 cycles (Bonde et al., 1998) . Epidemiological data also suggest a low implantation efficiency in vivo, with 20% or fewer women conceiving per cycle even when couples are fertile (Edwards and Brody, 1995) . These values compare with an average of 70% in captive baboons (Stevens, 1997), a species offering an exemplary model for humans since it has similar steroid profiles and presumably mono-ovulatory cycles (Henson, 1998) . Success rates in vivo depend, of course, on 2 several factors including fertilization rates and embryo quality as well as the chance of implantation.
Alternative and earlier approaches to selecting embryos with potentially high implantation rates depend on fundamental knowledge on the human embryo. We have recently suggested that mammals, including the human, display polarization in oocytes and cytoplasmic rotation at sperm entry, with closely co-ordinated cleavage planes partitioning polarized maternal transcripts specifically into individual blastomeres. This situation would be similar to that in a wide range of animals from amphibians to nematodes . Evidence exists of an anterior-posterior axis passing diametrically from the second polar body (Gardner, 1996; , and of an animal/ vegetal polarization of leptin and STAT3 in human oocytes and embryos (Antczak and Van Blerkom, 1997) , thus supporting our hypothesis. Payne et al (1997 Payne et al ( , 1998 recently published pictures and displayed a video showing superb examples of cytoplasmic rotation of the pronucleus and movement in human embryos. Searches must be made for distinct parameters of polarity, pronuclear rotation or the segregation of polarized proteins into blastomeres to identify the best-quality human oocytes and embryos. Some investigators have actually taken this approach, even if initially unaware that their findings might relate to polarity. Scott and Smith (1998) scored human pronucleate embryos for closely aligned pronuclei, polarity in nucleoli, heterogeneous cytoplasm, clear halos in cortex and around pronuclei, a dark central halo and an early first cleavage division. Points were awarded for these characteristics, varying betweeen 1 and 10. An embryo could gain a maximum of 15 points when pronucleate at 16-18 h post-insemination, and another 10 at 22-26 h post-insemination after an early first cleavage, giving a total maximum of 25 points (Scott and Smith, 1998) . Embryos with scores Ͼ15 produced implantation rates per embryo of 28%, whereas those with Ͻ14 produced rates of 2%. Pregnancy rates reached 71% with 3.7 highscoring embryos transferred (Scott and Smith, 1998) . These authors could add more parameters such as pronuclear polarity to calculate their score, which was based predominantly on early cleavage and pronuclear morphology. More than a decade ago, similar studies showed how early-dividing human embryos at the first and second cleavage divisions have implantation rates of 30% per embryo, much higher than those cleaving later (Edwards et al., 1984) . Benefits in early first cleavage have been shown again more recently, since these embryos had implantation rates per embryo of 26% as compared with 3.2% for later-cleaving embryos (Sakkas et al., 1998) . This benefit seems to persist into blastocysts, since pregnancy rates were 39% with those cryopreserved after blastulation on day 5 or 6 as compared with 6.2% with those blastulating on day 7.
The question arises as to whether blastocyst culture and pronuclear scoring are equally effective in selecting viable embryos. Gardner's (1998b) day 3 embryo and day 5 blastocyst transfers, and Scott and Smith's (1998) results together with their analyses by high or low corrected embryo scores are compared in Table I . Implantation rates per embryo transferred are impressively high for blastocysts (55.4%), considerably higher than 37% for 3 day transfers, 28% for high scoring embryos and only 2% for low-scoring embryos (Scott and a Those fertilized but not frozen and assuming none lost in 2-3 day culture (Scott and Smith, 1998) . N/A ϭ not available.
Smith, 1998). However if allowance is made for embryos lost in culture (46.5% for blastocyst development), the implantation rate per cultured embryo is 21%, just below that obtained in Scott and Smith's (1998) high-scoring embryos (i.e. 28%) but an improvement on their overall implantation rate (i.e. 15%). It is also notable that similar rates of pregnancy (71%) were established in the two best performing groups (blastocysts and high scoring pronucleate embryos), indicating that both selection methods target the same embryos. Surprisingly, blastocyst transfer yielded the highest multiple pregnancy rate. It can be concluded from Table I , that growth to blastocyst is the best selection for embryos capable of implantation since overall implantation rates per embryo when using blastocysts are higher than with pronuclear/2 cell transfers. This difference may arise through differences in centres, patient selection, or because the uterus is less favourable to cleaving embryos than to blastocysts. It is essential now to combine these approaches, scoring pronucleate embryos and then finding out if these are the embryos which grow to blastocysts in vitro. This would permit extra attention to be given to the best embryos, and media might be devised for several stages of their growth. There is no point in devoting energy to embryos incapable of implanting. They would best be studied in vitro to find out where they go wrong. Early selection criteria up to and including the first cleavage division avoid long-term culture, and may have advantages beyond this. Transcription levels particularly in the male pronucleus (Ram and Schultz, 1993; Ao et al., 1994) suggest that events at the 1-cell stage are critical for later development. This new outlook implies that more information can be gleaned on embryo quality by correctly assessing the pronucleate/2-cell embryo rather than other preimplantation stages. Transfers of 1-or 2-cell stages are fully acceptable because the human uterus seems to differ to those of other species, in that it is an excellent incubator for such early preimplantation embryos (Bavister and Boatman, 1997) . It is even possible to establish human pregnancies by transferring unfertilized eggs with zona-attached spermatozoa (Rizk et al., 1990) . For certain purposes, it remains essential to grow embryos to blastocysts, e.g. for preimplantation diagnosis of 3 inherited disease such as a reciprocal balanced translocation (Ménézo et al. 1997 ).
Yet, overall, the proportion of newly fertilized human embryos capable of implantation still remains Ͻ30%, whatever selection procedure is applied. This is the most disappointing statistic of human IVF and is only one of several observations which indicate a low degree of fertility in our species. All forms of IVF, including variations in ovarian stimulation and embryo culture, ultimately indicate a 20-25% rate of implantation per embryo in vivo and in vitro. All we are doing in IVF is selecting the best available embryos, and these are best identified at the blastocyst stage when all weaker embryos have died or arrested or by typing pronucleate eggs for polarity characteristics. We await with interest an explanation of why human semen samples contain so many abnormal spermatozoa, and why oocytes and embryos carry so many chromosomal anomalies and implant in very low numbers, while a woman has only 500 cycles or thereabouts in her whole lifetime and ovulates only a single egg in most of them! Do any other species display such an immense loss of reproductive potential? Perhaps cranial size and prolonged parent-child bonding have modified evolutionary pressures and restricted human reproduction to a few single births. ESCO-ESHRE Meeting, Milan, 1990 . Abstract No. 18, p. 5. Sakkas, D., Shoukir, Y., Chardonnens, D., et al. (1998 The development of suitable defined sequential culture media methods that can reliably lead to high rates of blastocyst development in human in-vitro fertilization (IVF) (Gardner et al., 1998a) has brought about the dilemma of when to apply this technique. As with many new IVF techniques, a choice must be made by many reproductive units of whether or not to adopt a new technology without compromising the ultimate goal of achieving pregnancies for couples. Gardner et al. (1998a,b) have stated that one of the most important applications of blastocyst transfer is that it will facilitate high pregnancy rates while limiting the number of embryos transferred and therefore minimize the risk of multiple gestation. Some pitfalls to the use of blastocyst culture exist. One being that, of those embryos that fail to reach the blastocyst stage in vitro, how many would have been able to give rise to offspring if transferred earlier? In addition, as not all embryos develop to the blastocyst stage, many couples who have a small number of fertilized embryos would risk not having an embryo transfer. A possible cut-off point of the number of fertilized embryos may also need to be adopted by some clinics before blastocyst culture can be offered. Blastocyst culture could, therefore, not be comfortably offered to all patients. In patients who have limited numbers of fertilized embryos, other criteria should be obtained to select the best embryos. One method is that of selecting the earliest cleaving embryos to the 2-cell stage, whereby a strict time-point after fertilization is used to choose the embryos to transfer (Shoukir et al., 1997a) .
The most important benefit of blastocyst culture is that it offers an excellent, simple non-invasive means of selecting the best embryo to transfer. In conjunction with the rate of blastocyst development, embryos with a high developmental potential can be selected for transfer (Lelaidier et al., 1995; Shoukir et al., 1998a) . It is this ability to select highly viable embryos by non-invasive means that may prove crucial when using blastocyst culture. This will be of greater benefit when we use assisted reproductive techniques (ART) that may compromise the quality of the embryo produced. One example where embryo quality may be diminished is when using intracytoplasmic sperm injection (ICSI).
The use of blastocyst culture may therefore have a more direct benefit in its application to assisted reproduction. There is already considerable discussion as to whether ICSI may contribute to an increase in the development of abnormal offspring (Bonduelle et al., 1998; Bowen et al., 1998) . With the use of ICSI, we have become less discriminatory with the quality of paternal nuclear material we introduce into the egg. Spermatozoa possessing defective chromatin packaging (Evenson et al., 1980) , damaged DNA (Gorzyca et al., 1993; Sakkas et al., 1997) and those that have not completed spermatogenesis (Fishel et al., 1995) are being used to treat infertile men. It has been argued for several years, that sperm defects could impair not only the fertilization process but also the fate of embryos.
The effect of various sperm anomalies on embryo quality is supported by a number of studies. Using strict criteria, a relationship between embryo quality and the degree of 'normality' of a semen sample regarding morphological features has been observed (Ombelet et al., 1994) . In clinical in-vitro fertilization (IVF), when the usual parameters of sperm quality are good, there is a strict linear relationship between cleavage and blastocyst formation. For spermatozoa with poor motility and poor morphology parameters, cleavage rate did not correlate with further embryonic development. When fertile abnormal spermatozoa are used in IVF, no correlation exists between the sperm fertility estimated by the cleavage rate and the development potential of the embryos assessed by the blastocyst formation rate. Janny and Ménézo (1994) showed that poor quality spermatozoa may lead to poor rates of blastocyst formation, but once the blastocyst stage is obtained the developmental future is equal whatever sperm quality at the origin. In the human we have recently reported that ICSI patients have a lower percentage of embryos that form blastocysts compared with patients undergoing routine IVF (Shoukir et al., 1998b) . This, however, needs confirmation in a larger study using newly defined media.
How can we lessen the possibility that ICSI offspring will inherit a defective paternal genome? The options are, either to preselect the best spermatozoon to use for ICSI, or to use a selection process to identify the embryo that is more likely to develop into a normal offspring. Adopting the use of extended culture to the blastocyst stage offers the second possibility for ICSI patients. The use of blastocyst culture will, therefore, provide us with a number of benefits. Along with the ability to confidently select more viable embryos and limit the chances of multiple pregnancy, blastocyst culture may provide a non-invasive means of weeding out the abnormal embryos. In doing so, this may in turn lessen the chance of an errant paternal genome being inherited by ICSI offspring.
Human blastocyst culture without co-culture and subsequent embryo transfer is a tool now available to in-vitro fertilization (IVF) centres around the world. With the advent of new commercially available sequential culture media systems (P1 and blastocyst and S1 and S2), viable blastocysts may now be attained at a relatively high rate (on average ജ50%) yielding high implantation rates (50%) when transferred into the uterus on day 5 or 6 of culture (Gardner et al., 1998; Behr et al., 1999) . One issue that must be recognized is that we cannot compare old technology with new. There was a significant development in IVF media technology in the mid-1990s (Gardner et al., 1994; T.B.Pool, personal communication) and Gardner and Lane (1997) recently demonstrated in a mouse model that the previous assumption of simply forming a blastocyst does not equal viable blastocyst and proposed this for the human system. These developments were the first culture systems designed specifically for human embryo extended culture using the specific energy sources and amino acids with the specific intent of developing viable embryos since the introduction of human tubal fluid (HTF) in the 1980s (Quinn et al., 1985) . Blastocyst development potential in vitro without co-culture is different now since these developments.
